Zentek Announces Appointment of Mohammed Jiwan as Chief Executive Officer

Executive Summary

• Zentek Ltd. appoints Mohammed (Moe) Jiwan as Chief Executive Officer and director, effective December 1 2025.
• The board thanks interim CEO/CFO Wendy Ford for her service and confirms she will remain CFO.
• Concurrently, the company grants stock options for 475,000 common shares at $1.06 each (three‑year term) and 425,000 restricted share units to certain officers, directors and consultants.

Key Details

• CEO Appointment: Mohammed “Moe” Jiwan – over 20 years of experience in operational leadership, capital markets, technology, healthcare and life‑science sectors; will also serve as a director.
• Effective Date: December 1 2025.
• Board Statement: Chair John Snisarenko highlighted the appointment as a “disciplined transformation” for Zentek.
• CEO Quote: Jiwan expressed commitment to unlocking technology value, securing capital and delivering commercial progress.
• Interim CEO Transition: Wendy Ford steps down as interim CEO but continues as Chief Financial Officer.
• Equity Compensation Grant (effective Nov 25 2025):
• Stock options for an aggregate of 475,000 common shares at a grant price of $1.06 per share, exercisable over three years; vesting schedule – 1/3 on grant date, 1/3 on Dec 1 2026, 1/3 on Dec 1 2027.
• Restricted Share Units (RSUs) for an aggregate of 425,000 shares, vesting on Dec 1 2026.
• All securities subject to a four‑month hold period from the grant date.

Notable Quotes

• “Today's announcement is more than a leadership transition; it marks the beginning of a disciplined transformation of our Company,” – John Snisarenko, Chair, Board of Directors.
• “I am honored and proud to lead the Zentek team… Our mandate now is to unlock the full value of our technologies and assets, secure the capital required to grow, and deliver on the commercial progress our shareholders deserve,” – Mohammed (Moe) Jiwan, CEO.